Camarillo, CA, United States of America

Peter Syapin

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Peter Syapin

Introduction

Peter Syapin is an accomplished inventor based in Camarillo, California. He has made significant contributions to the field of medical treatments, particularly focusing on alcohol use disorder and related inflammatory processes. With a total of two patents to his name, Syapin's work is paving the way for new therapeutic approaches.

Latest Patents

Syapin's latest patents include a method for treating Alcohol Use Disorder (AUD) and Substance Use Disorder (SUD) using modified tetracycline. This innovative method involves providing a subject with an effective amount of a modified tetracycline or its derivative to ameliorate or eliminate AUD, SUD, tobacco use, pain, or proinflammatory disorders. The modified tetracycline has reduced binding to a microbial ribosome and is characterized by a specific chemical formula where R1 is acetyl, R2 is OH or acetyl, R3 is acetyl, R4 is H or acetyl, and R5 is acetyl.

Career Highlights

Peter Syapin is affiliated with the Texas Tech University System, where he continues to advance his research and innovations. His work is instrumental in developing new methods for treating complex disorders that affect many individuals.

Collaborations

Some of his notable coworkers include Susan E. Bergeson and Ted W. Reid, who contribute to the collaborative efforts in research and development within the university system.

Conclusion

Peter Syapin's innovative work in the field of medical treatments showcases his dedication to improving health outcomes for individuals suffering from various disorders. His patents reflect a commitment to advancing therapeutic methods that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…